Pyruvate Kinase Assay Kits

Assay Principle

Pyruvate kinase (PK, also known as ATP:pyruvate 2-O-phosphotransferase, with tissue-specific isoforms including PKM1, PKM2, and PKLR) catalyzes the final, ATP-generating step of glycolysis, transferring a phosphate from phosphoenolpyruvate (PEP) to ADP to yield pyruvate and ATP. A pyruvate kinase assay typically couples this reaction to a second enzymatic step: one common format uses lactate dehydrogenase to convert the pyruvate product while oxidizing NADH, with PK activity calculated from the resulting decrease in absorbance at 340 nm. An alternative format instead couples pyruvate to pyruvate oxidase, generating a signal detected colorimetrically around 570 nm or fluorometrically near Ex/Em 535/587 nm, offering flexibility depending on the instrumentation and sensitivity required.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are broadly validated across serum, plasma, tissue, and cell lysates (including adherent and suspension cell cultures), with reported sensitivity in the sub-1 U/L range for the NADH-coupled format and roughly 0.1 mU/mL for the pyruvate oxidase-coupled format, and assay times ranging from about 30 minutes to 40 minutes depending on kit and readout. Because both coupling chemistries rely on a second enzyme functioning correctly, confirming that samples do not contain interfering substances for lactate dehydrogenase or pyruvate oxidase is important for accurate results, and including the kit's positive control on each plate helps verify the coupled reaction is behaving as expected. Dilution factors are comparatively modest and consistent across tissue types (commonly 4- to 6-fold for tissue homogenates and no dilution for most serum, plasma, or cell lysates), which simplifies protocol planning relative to some other glycolytic enzyme assays.

Assay Kit Purchasing Considerations

The choice between NADH-coupled and pyruvate oxidase-coupled detection for measuring pyruvate kinase activity largely comes down to existing instrumentation and desired sensitivity, with the oxidase-coupled colorimetric/fluorometric format offering flexibility across plate reader types. For cancer metabolism research, where PKM2 upregulation and altered isoform expression support the Warburg effect and tumor cell proliferation, confirming that a kit's validated cell line coverage and sensitivity suit the specific cancer model under study is a practical consideration. Researchers studying pyruvate kinase deficiency, a hereditary cause of hemolytic anemia linked to PKLR mutations, should also confirm that a kit's detection range extends low enough to reliably distinguish deficient red blood cell samples from normal controls, since this application requires resolving activity differences at the lower end of the assay's dynamic range. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.